Industry News
Scientists Decode "Software" Instructions Of Aggressive Leukemia Cells
Oct 31, 2012
Researchers Locate Molecules that Drive the Development of Three Forms of Deadly White Blood Cell Cancers, Pointing Researchers to New Potential Therapeutic Targets A team of national and international researchers, led by Weill Cornell Medical College scientists, have decoded the key "software" instructions that drive three of the most virulent forms of acute lymphoblastic leukemia (ALL)... Read More
Sildenafil Citrate Improves Overall Sexual Function Of Prostate Cancer Patients Receiving Radiation Therapy
Oct 31, 2012
Sildenafil citrate (SC), a phosphodiesterase type 5 inhibitor, administered before, during and after radiation therapy improved overall sexual function of prostate cancer patients, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting... Read More
Memantine Delays Cognitive Decline In Brain Tumor Patients Who Receive Whole Brain Radiation Therapy
Oct 31, 2012
Memantine, an N-Methyl-D-aspartate receptor antagonist typically prescribed to Alzheimer's patients, slows cognitive decline in brain cancer patients who receive whole brain radiation therapy (WBRT), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting... Read More
Astrazeneca Begins A New Global Study Of Faslodex® (Fulvestrant) 500 MG Injection In Patients With Hormone Receptor-Positive Advanced Breast Cance
Oct 31, 2012
FALCON (Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naïve advanced breast cancer) trial to compare fulvestrant to anastrozole (ARIMIDEX®) tablets in hormonal therapy-naïve, postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer... Read More
Scientists Decode "Software" Instructions Of Aggressive Leukemia Cells
Oct 31, 2012
Researchers Locate Molecules that Drive the Development of Three Forms of Deadly White Blood Cell Cancers, Pointing Researchers to New Potential Therapeutic Targets A team of national and international researchers, led by Weill Cornell Medical College scientists, have decoded the key "software" instructions that drive three of the most virulent forms of acute lymphoblastic leukemia (ALL)... Read More
Sildenafil Citrate Improves Overall Sexual Function Of Prostate Cancer Patients Receiving Radiation Therapy
Oct 31, 2012
Sildenafil citrate (SC), a phosphodiesterase type 5 inhibitor, administered before, during and after radiation therapy improved overall sexual function of prostate cancer patients, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting... Read More
Memantine Delays Cognitive Decline In Brain Tumor Patients Who Receive Whole Brain Radiation Therapy
Oct 31, 2012
Memantine, an N-Methyl-D-aspartate receptor antagonist typically prescribed to Alzheimer's patients, slows cognitive decline in brain cancer patients who receive whole brain radiation therapy (WBRT), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting... Read More
Astrazeneca Begins A New Global Study Of Faslodex® (Fulvestrant) 500 MG Injection In Patients With Hormone Receptor-Positive Advanced Breast Cance
Oct 31, 2012
FALCON (Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naïve advanced breast cancer) trial to compare fulvestrant to anastrozole (ARIMIDEX®) tablets in hormonal therapy-naïve, postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer... Read More
Molecules That Drive The Development Of 3 Forms Of Leukemia Point To New Potential Therapeutic Targets
Oct 31, 2012
A team of national and international researchers, led by Weill Cornell Medical College scientists, have decoded the key "software" instructions that drive three of the most virulent forms of acute lymphoblastic leukemia (ALL)... Read More
Quality Of Life For Men With Prostate Cancer Preserved By Proton Therapy Treatment
Oct 31, 2012
Two studies led by The University of Texas MD Anderson Cancer Center have found that proton therapy preserves the quality of life, specifically urinary and bowel function, in men treated with this targeted radiation modality for prostate cancer. Both studies, led by Andrew K. Lee, M.D., M.P.H... Read More
Previous Page Next Page